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ToxicologyAccording to early experiments with natural extracts, phosphatidylcholines (PCs) are widely considered essen-
tially non-toxic. In addition to these physiological mixed-chain PCs, many different synthetic diacyl-PCs are cur-
rently available, but they have never been systematically evaluated for any interference with cell proliferation.
We thus investigated the cell proliferation of several cell lines in the presence of various liposomes consisting
of a single PC component and cholesterol.
Most of the PCs investigated did not interferewith cell proliferation, supporting the notion thatmost PCs are safe
excipients. Signiﬁcant IC50 values below 0.5 mM were detected for PC(12:0/12:0), PC(14:1/14:1)trans and all
diacyl-PCs containing two polyunsaturated fatty acids (PUFAs). The ω-3 PC(22:6/22:6) was the most toxic PC
assessed, revealing IC50 values below 100 μM, but no rule concerning ω-3/6 conﬁguration or acyl chain length
could be observed. Physiological mixed-chain PCs containing PUFAs were much less toxic than respective non-
physiological diacyl-PCs. All trans fatty acids in diacyl-PCs interferedmorewith proliferation than their respective
cis-conﬁgured counterparts. Depending on the concentration, those diacyl-PCs not only inhibited proliferation
but also induced cell death.
Unlike the non-toxic PCs usually used for liposomal drug delivery, the elucidated diacyl-PCs may be worthy of
further examination to eventually construct a toxic shell for toxic drugs, thereby enhancing anticancer drug de-
livery via lipid particles.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Phosphatidylcholines (PCs) are omnipresent building blocks of al-
most all living organisms. As a key feature of this amphipathic substance
class, PCs spontaneously form lipid bilayer structures in aqueous sur-
roundings, and are major constituents in animal and human cell mem-
branes [1]. They are chemically characterized by a glycerol core linked
via an sn-3-phosphodiester to a choline head group, and two acyl chains
are esteriﬁed in sn-1- and sn-2-positions.While the choline head group
is the deﬁning moiety, the fatty-acid (FA) acyl chains vary for different
PCs.With respect to biological functionality, the sn-1 and sn-2 positions
differ widely. Most natural PCs are mixed-chain PCs, having differentolyunsaturatedfattyacid;HSPC,
-hydroxy-phosphatidylcholine;
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. This is an open access article underFAs in their sn-1 and sn-2 positions. Diacyl-PCs, showing the same FAs
in sn-1 and sn-2 positions, are common in neither yeast [2] nor
mammalian cells [3], except for PC(16:0/16:0), PC(16:1/16:1) and
PC(18:1/18:1). With regard to their spontaneous membrane-building
properties, PCs are often referred to as a homogeneous class of sub-
stances, although it is well known that many biophysical and biochem-
ical properties of various PCs dependon their FA acyl chain components.
Even minor chemical changes in acyl chain structure, such as adding a
double bond or two hydrocarbons, trigger major differences in mem-
brane characteristics such as phase transition or miscibility with other
membrane components. Poor miscibility of membrane lipids leads to
microdomain formation in cellular membranes. These microdomains
are crucial for cellular function, as the functionality of several receptors
and membrane enzymes relies on a speciﬁc lipid environment [4].
PCs were initially characterized from natural extracts such as egg PC
or soy PC. Not surprisingly, these PC mixtures were shown to be non-
toxic in vitro [5] and in vivo. IC50-values of several grams of egg PC per
kg body weight were determined in mice [6,7]. A growing number of
synthetic and non-natural PCs became available over the years, mostly
diacyl-PC. Interestingly, PCs are generally regarded as non-toxic even
though these pure components have never undergone systematic eval-
uation with respect to interference with cell proliferation.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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vesicles in water, PCs have been intensively investigated for drug-
delivery purposes. Themost successful vesicular approach to drugdeliv-
ery are small unilamellar liposomes in a size range of about 100 nm, al-
ready in clinical practice for many years [8]. Major constituents of these
liposomes are PCs and cholesterol besides minor components like PEG-
linked lipids used for functional surface modiﬁcations. While many
different drugs have been encapsulated and their impact intensively
characterized in vitro and in vivo, possible interaction between a specif-
ic liposomal PC and cell proliferation has been generally neglected.
PCs may be hydrolyzed to free fatty acids (FFAs) and lysolipids, a re-
action catalyzed by omnipresent phospholipases A. Saturated lysolipids
have been shown to inhibit the metastatic spread of cancer cells in a
metastatic mouse model [9]. In contrast to PCs, FFAs are generally con-
sidered to possess some toxic potential by uncoupling the electron
chain in mitochondria [10] or acting as a detergent to permeabilize
membranes [11]. FFA toxicities vary with the FA acyl chain's chemical
structure. FFAs are utilized as a natural defense against bacteria in sev-
eral species including humans [12], and polyunsaturated fatty acids
(PUFAs) have attracted some interest as anticancer agents in vitro
(e.g..[13,14,15] and in vivo [16,17]).
In mammalians, lipids are transported by lipoproteins, which are
covered by a phospholipid monolayer. As major functional components
of lipoproteins, PCs are related to severe human threats like cardiovas-
cular diseases and diabetes [18]. Several epidemiologic studies have
demonstrated FAs' key impact on human health concerning the nutri-
tional intake of ω-3 and ω-6 FAs or cis/trans-conﬁgured unsaturated
FAs [19,20].
Unfortunately, the systematic evaluation of FFA toxic effects is made
difﬁcult because of differences in solubility, binding characteristics to
cells, materials and transporting proteins like albumin. Further, various
FFAs possess different membrane-transport properties, hindering sys-
tematic comparison. The use of liposomes as delivery vehicles for
diacyl-PCs of different FA compositions may overcome this drawback.
The aim of this examination was to systematically evaluate various
diacyl- and somemixed chain-PCs with respect to possible interference
with cell proliferation. Furthermore, we attempted to identify possible
candidates to construct a “toxic shell for toxic drugs”, such as chemo-
therapeutic agents, to potentially enhance the impact of liposomal
drugs in anticancer therapy.
2. Material and methods
2.1. Materials
PCs were purchased from Avanti Polar Lipids (Alabaster, AL, USA),
cholesterol as well as CHCL3 essential purity 99.8% stabilized with
amylenes was derived from Sigma-Aldrich® (St. Louis, MO, USA).
[1,2-3H]Cholesterylhexadecylether (1.9 TBq/mMol) was obtained from
American Radiolabeled Chemicals (Saint Louis, MO, USA) and I-α-
dipalmitoyl-1-14C-phosphatidylcholinewas obtained from PerkinElmer
Life Science Products (Waltham, MA, USA). All other chemicals were of
the highest quality available from commercial sources.
2.2. Chemistry of PCs
The 1-acyl-2-acyl-PCs usedwere noted as PC(1-acyl/2-acyl), respec-
tive FAs as FA (number of carbon atoms:double bonds) as is standard.
The exact position and stereochemistry of double bonds are not stated
in the text for reasons of enhanced legibility. The following chemical
names and CAS numbers apply to the PCs used:
PC(10:0/10:0): 1,2-didecanoyl-sn-glycero-3-phosphocholine,
[3436-44-0]; PC(12:0/12:0): 1,2-didodecanoyl-sn-glycero-3-phos-
phocholine [18194-25-7]; PC(14:0/14:0): 1,2-ditetradecanoyl-sn-
glycero-3-phosphocholine [18194-24-6]; PC(16:0/16:0): 1,2-
dihexadecanoyl-sn-glycero-3-phosphocholine [63-89-8]; PC(20:0/20:0): 1,2-dieicosanoyl-sn-glycero-3-phosphocholine [61596-53-
0]; PC(14:1/14:1)cis: 1,2-di-(9Z-tetradecenoyl)-sn-glycero-3-
phosphocholine [56750-90-4]; PC(14:1/14:1)trans: 1,2-di-(9E-
tetradecenoyl)-sn-glycero-3-phosphocholine [76733-52-3]; PC(16:1/
16:1)cis: 1,2-di-(9Z-hexadecenoyl)-sn-glycero-3-phosphocholine
[4724-96-3]; PC(16:1/16:1)trans: 1,2-di-(9E-hexadecenoyl)-sn-
glycero-3-phosphocholine [56816-00-3]; PC(18:1/18:1)cis: 1,2-di-(9Z-
octadecenoyl)-sn-glycero-3-phosphocholine [4235-95-4]; PC(18:1/
18:1)trans: 1,2-di-(9E-octadecenoyl)-sn-glycero-3-phosphocholine
[56782-46-8]; PC(18:2/18:2)allcis: 1,2-di-(9Z,12Z-octadecadienoyl)-
sn-glycero-3-phosphocholine [998-06-1]; PC(18:3/18:3)allcis: 1,2-
di-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phosphocholine
[2701-19-1]; PC(20:4/20:4)allcis: 1,2-di-(5Z,8Z,11Z,14Z-
eicosatetraenoyl)-sn-glycero-3-phosphocholine [17688-29-8];
PC(22:6/22:6)allcis: 1,2-di-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-
sn-glycero-3-phosphocholine [99296-81-8]; PC(18:0/14:0): 1-
octadecanoyl-2-tetradecanoyl-sn-glycero-3-phosphocholine [20664-
02-2]; PC(16:0/18:1cis): 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-
glycero-3-phosphocholine [26853-31-6]; PC(18:1cis/16:0): 1-
(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine
[59491-62-2]; PC(16:0/20:4allcis): 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-
eicosatetraenoyl)-sn-glycero-3-phosphocholine [35418-58-7];
PC(16:0/22:6allcis): 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-
docosahexaenoyl)-sn-glycero-3-phosphocholine [59403-54-2].
2.3. Cell lines and cultivation
Chinese hamster ovarian wild type (CHO-K1) cells (ATCC® CCL61™,
American Type Culture Collection, Manassas, USA) were cultured in
HAM's F-12medium (Promo Cell®, Heidelberg, Germany), supplement-
ed with 10% (v/v) FCS (PAA, Pasching, Austria). Rattus norvegicus, mam-
mary gland adenocarcinoma (MAT-B-III) cells (ATCC® CRL1666™) and
MES-SA cells (ATCC® CRL1976™) were cultured inMcCoy's 5Amedium
(Sigma-Aldrich®), supplemented with 10% (v/v) FCS and 1.5 mM L-
glutamine. HL-60 cells (ATCC® CCL240™) were cultivated using RPMI
1640 (Sigma-Aldrich®) supplemented with 2 mM L-glutamine and 10%
FCS. Mouse embryonic ﬁbroblast (MEF) cells (ATCC® SCRC1008™)
were cultured in DMEM – high glucose –medium containing 4.5 g/l glu-
cose (Biochrom GmbH, Berlin, Germany) supplemented with 10% (v/v)
FCS and 1 μl/ml EtSH. Pooled human umbilical vein endothelial cells
(HUVEC, cat. no. 1223) were purchased from PromoCell GmbH
(Heidelberg, Germany) and cultivated using Endothelial Cell Growth
Medium supplemented with Supplement Mix (containing 2% FCS) pur-
chased from PromoCell as well.
Usually 75 ml cell culture ﬂasks (Cellstar®, Greiner Bio-One,
Kremsmünster, Austria)were used to harbor the cells. All cellswere cul-
tured in a humidiﬁed 5% CO2 atmosphere at 37 °C, and MEF cells were
protected by penicillin/streptomycin antibiotics.
2.4. Preparation and characterization of liposomes
Liposomes were prepared by extrusion technique [21]. Brieﬂy, PCs
were dissolved in CHCl3 (10 mg/ml), mixed to a total amount of
~40 mg with 70 mol% PC and 30 mol% cholesterol. For radioactive
measurements 0.6 μCi/μmol lipid [1,2-3H]cholesterylhexadecylether
(cholesterylhexadecylether) and/or I-α-dipalmitoyl-1-14C-
phosphatidylcholine were added to the lipids during preparation.
A dry ﬁlm was prepared by evaporating the solvent in a vacuum.
Lipids were then suspended in 1 ml of liposome buffer (LB) containing
118 mM NaCl, 4.74 mM KCl, 1.2 mM MgCl2, 0.59 mM KH2PO4,
0.59 mMNa2HPO4, 10 mMHEPES adjusted to pH 7.4. The extrusion de-
vice LiposoFast™ (Milsch-Equipment, Laudenbach, Germany) used was
equipped with polycarbonate ﬁlters (Milsch-Equipment). Routinely,
the samples were ﬁrst extruded 21 times through one ﬁlter with a
pore diameter of 200 nm and subsequently 21 times through two
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somes were stored at 4 °C for a maximum of 7 days.
Particle size distribution of manufactured liposomes was deter-
mined by photon correlation spectroscopy on a Submicron Particle
Sizer NICOMPTM 380 (Particle Sizing Systems, St. Barabara, California,
USA). Liposomes were diluted with LB to yield a count rate of
~300 kHz. Themeasurementwas done at 23 °C for 10min. For viscosity
and refractivity standard parameters were used. Data were processed
by NICOMP-software according to “Gaussian intensity weighting”. To
use this calculation, the chi2 had to be less than 3. Depending on the
PC, the average size varied between 77 (±52) nm and 119 (±44) nm.
The measured sizes fell within the range expected for liposomes pre-
pared by extrusion.
PC concentrationsweremeasured via the colorimetricmethod using
ferrothiocyanate [22]. In 2-ml-vials 1 ml of CHCL3 and 750 μl of a
ferrothiocyanate solution containing 0.4 M ammonium thiocyanate
and 0.1 M FeCl3 in dest. water were prepared. Liposomal preparations
were diluted 1:19 (v/v) with LB and 25 μl of this dilution were added
to each vial. LB was used as blank. The vials were mixed vigorously. To
separate phases the vialswere centrifuged at 4000 g for 5min. The aque-
ous supernatant was aspired; remaining traces of red ferrothiocyanate
solution were removed with the help of cotton buds. The extinctions
of the organic phases were measured in glass cuvettes at 485 nm. For
each preparation 5 replicates were measured. Individual calibration
curves for respective lipids had to be used since thedifferent PCs showed
variations in extinction.
2.5. Cell proliferation assay
Adherent cells were seeded at 0.5 × 106 cells/ml in 96-well tissue
culture plates (Cellstar®, Greiner Bio-One, Kremsmünster, Austria).
After 4 h of incubation, the cell culture medium was removed and
media containing liposomes at different concentrations were added.
HL-60 cells were seeded at 2 × 106 cells/ml and allowed to settle for
2 h until the medium was aspired carefully and liposomes containing
mediawere added. Since liposomeswere not prepared under strict ster-
ile conditions, liposome preparations were ﬁrst diluted to ~2.2 mM in
respective cell culturemedia thatwere phenol-red free. To prepare ster-
ile cell culture media, these liposome suspensions were subjected to ﬁl-
tration under sterile conditions by a ﬁlter with 0.45 μm pore size
(Millex®-HV, Merck Millipore, Merck KGaA Darmstadt, Germany).
Loss of PC due to ﬁltration was about 10% on average. PC contents
were measured and respective volumes added to the cell culture wells
containing media to yield a total volume of 100 μl/well. To investigate
possible interference of PCs with cell proliferation, liposomes were
added to yield ﬁnal concentrations of 0.01; 0.05; 0.1; 0.25; 0.5 and
1mM liposomal PCs and proliferationwasmeasured after 96 h.With re-
spective mixed-chain PCs 2 mM liposomal PCs were investigated as
well. To investigate the time course of proliferation in presence of
PC(12:0/12:0), PC(14:1/14:1)trans or PC(18:3/18:3)allcis respective li-
posomes were added in concentrations of 0.05, 0.25 or 1 mM liposomal
PC and proliferation was compared to untreated controls after 4, 8, 24,
48, 72 or 96 h.
Proliferation was measured using the MTT-assay (Roche, Basel,
Switzerland) [23]. Media containing liposomes were removed and
cells were washed twice with LB. Cell culture wells were then ﬁlled
with 100 μl of respective cell culture media without FCS and without
phenol red and 10 μl of MTT solution containing 5 mg/ml of 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide were added
to each well. After 4 h of incubation, cells were killed by adding 100 μl
of 10% (w/v) SDS in 0.01 M HCl. Culture plates were kept for 24 h
under cultivating conditions to solubilize possible tetrazolium crystals,
then adsorption was measured at 500 nm wavelength. All measure-
ments were taken in triplicate.
Each culture plate contained untreated cells, and proliferation was
estimated as percent of these untreated controls. Interference withcell proliferation was investigated between 0.01 and 1 mM liposomal
PC. When the course of proliferation was measured, proliferation was
estimated as percent of untreated cells at t = 0.
2.6. Binding and uptake of liposomes into cells
Cells were cultivated as described and seeded into a 24-well cell
culture plate. Isotopic labeled liposomes were added to the cell cul-
ture wells to yield a ﬁnal PC-concentration of 1 mM. Association
between liposomes and cells was measured by adding labeled
cholesterylhexadecylether, possible PC hydrolysis was investigated by
adding radioactive labeled cholesterylhexadecylether as marker for
whole particle uptake and I-α-dipalmitoyl-1-14C-phosphatidylcholine
as marker for uptake of isolated PC or hydrolysis products thereof.
After different time points, the media containing liposomes were as-
pired and cells washed 3 times with 0.5 ml LB. Then cells were lysed
by adding 0.5 ml of 0.5% (w/v) SDS and 0.1% (v/v) Triton-X-100 in
200 mM NaCl.
Radioactivity was determined via a liquid scintillation counter
Wallac 1411 (Berthold, Wildbad, Germany) using internal quench cor-
rection. The samples (200 μl) weremixed with 3.5 ml of liquid scintilla-
tion cocktail (Ultima Gold®, Canberra Packard GmbH, Frankfurt,
Germany) and allowed to rest for at least 6 h in the dark before we
started to count liquid scintillation.
Protein content of cultured hepatocytes was determined by a modi-
ﬁed Lowry procedure [24], using the DC protein determination assay
(BioRad Life Science Group, Germany). Bovine serum albumin, dis-
solved in the solution used for dissolving the cells, was used as a
standard.
2.7. Thin layer chromatography of lipids
Cells were cultivated in FCS free medium containing 0.5 mM liposo-
mal PC, and cell culture supernatant was collected after different culti-
vation periods. Lipids were extracted according to Bligh & Dyer [25].
PC, lyso-PC and free fatty acids separated by TLC on silica coated plates
60F254 (E. Merck, Darmstadt, Germany) with CHCl3/methanol/H2O
(65/25/4) (v/v/v). Phospholipids were visualized by spraying with
1.3% molybdenum blue spray (Sigma-Aldrich) [26]. Oleic acid (Sigma-
Aldrich®), 1-palmitoyl-2-hydroxy-sn-glycero-phosphocholine (Avanti
Polar Lipids) and PC(14:1/14:1)cis were used as references. Oleic acid
was determined using 0.1 M KMnO4. Trace amounts of possible hydro-
lysis products were investigated by adding I-α-dipalmitoyl-1-14C-
phosphatidylcholine labeled liposomes to the cells. Spots were scraped
off and radioactivity measured by liquid scintillation counting (Wallac
1411, Berthold, Wildbad, Germany).
2.8. Mathematical methods
To compute and visualize data, Slide Write Plus 7.01 (Advanced
Graphics Software Inc., Ranco Santa Fe, CA, USA) was used. Mean and
s.d. were calculated according to standard equations. IC50 values were
calculated by ﬁtting a 4 parameter logistic dose response curve (Eq. 1)
to the experimental data using the least square method.
y ¼ a0þ a1= 1þ x=a2ð Þ3
 
ð1Þ
with ai being the coefﬁcients to ﬁt and a2 the parameter corresponding
to the IC50.
The conﬁdence intervals (CI) of ﬁtted parameter were calculated ac-
cording to Eq. (2):
CIi ¼ ai  t 1‐α=2; n‐pð Þ  SEai ð2Þ
SEai ¼ sqrt MSE  cið Þ ð3Þ
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c ¼ XTX−1n ð4Þ
wherein X is the design matrix, XT the transposed matrix X and 1n the
identity matrix.
MSE is the mean square error given by the error sum of squares
(SSE) according to:
MSE ¼ SSE= n‐pð Þ ð5Þ
with n the number of sample data and p the number of coefﬁcients.
In general 95%-CI is given.
3. Results
3.1. PC interference with cell proliferation
To detect possible PC interference with cell proliferation, the reduc-
tion of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
was used (MTT-Assay system) [23]. This reaction is directly related to0.
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Table 1
Inhibition of cell proliferation by different diacyl PC. Cells of various cell lines were grown in the presence of liposomes (70 mol% PC/30 mol% cholesterol) for 96 h. Cell proliferation was
measured via MTT-assay and proliferation provided relative to untreated controls. Where appropriate, an IC50-concentration was calculated using a 4-parameter logistic dose–response
function and respective correlation coefﬁcients are given as r while CI gives the 95%-conﬁdence intervals. When no growth inhibition N50% up to a concentration of 1 mMwas detected,
respective IC50-value is stated as N1, undetermined values are left empty. All PCs tested were 1,2-diacyl-PC and respective FAs are given in carbon reference systematic.
PC saturated PC monounsaturated PC polyunsaturated
cis trans all cis
Cell line 10:0 12:0 14:0 16:0 20:0 14:1 16:1 18:1 14:1 16:1 18:1 18:2 18:3 20:4 22:6
CHO-K1 IC50 [mM] 0.68 0.19 N1 N1 N1 N1 N1 N1 0.44 N1 N1 0.22 0.20 0.28 0.08
CI 0.41–0.93 0.09–0.28 0.30–0.58 0.16–0.28 0.17–0.23 0.21–0.34 0.07–0.09
r 0.97 0.99 0.98 0.99 0.99 0.98 0.99
MAT-B-III IC50 [mM] 0.51 0.36 N1 N1 N1 N1 N1 N1 0.42 0.58 N1 0.39 0.06 0.18 0.02
CI 0.36–0.67 0.14–0.49 0.19–0.65 0.31–0.85 0.07–0.71 0.04–0.07 0.05–0.32 0.01–0.03
r 0.99 0.98 0.96 0.99 0.91 0.99 0.99 0.99
HL-60 IC50 [mM] 0.16 0.35 N1 0.85 N1 0.17 0.09 0.07 0.07
CI 0.11–0.21 0.13–0.57 0.40–1.3 0.13–0.22 0.07–0.12 0.06–0.08 0.04–0.11
r 0.99 0.99 0.99 0.99 0.86 0.99 0.99
MES-SA IC50 [mM] 0.26 N1 N1 0.55 0.10
CI 0.25–0.28 0.46–0.64 0.09–0.11
r 0.99 0.98 0.99
MEF-WT IC50 [mM] 0.65 1.00 N1 N1 N1 0.26 0.28 0.09
CI 0.47–0.83 0.83–1.2 0.23–0.29 0.23–0.33 0.05–0.12
r 0.99 0.98 0.99 0.99 0.97
HUVEC IC50 [mM] 0.18 N1 N1 0.13 0.08
CI 0.09–0.28 0.05–0.27 0.02–0.13
r 0.99 0.98 0.97
The bold entries are highlighted to identify measured IC50 values.
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appear slightlymore susceptible to PC-mediated toxicity in general. Sat-
urated PCs with longer side chains than PC(12:0/12:0) displayed no or
minimal interference with cell proliferation. Interestingly, the natural
PC(16:0/16:0) always revealed slight inhibition of cell proliferation in
all cell lines. Again, HL-60 cells weremore susceptible, andwe observed
an IC50 of ~0.9 mM. Stable PC(18:0/18:0)-liposomes were not
preparable by the simple extrusion technique used, so we used hydro-
genated soy PC (HSPC) as a surrogate for PC(18:0/18:0). According to
the manufacturer, HSPC contains ~89% FA(18:0), thus ≥78% of HSPC
has to be PC(18:0/18:0). Like all extracts from natural sources investi-
gated in earlier work, HSPC did not demonstrate increased inhibition
of cell proliferation. Taken together, there is no clear-cut correlation be-
tween toxicity and chain length, but short chain diacyl PCs do reveal el-
evated toxicity, and PC(16:0/16:0) can interfere with cell proliferation
at high concentrations.
All the monounsaturated PCs in cis-conﬁguration we investigated
showed little or no interference with cell proliferation, with only
PC(14:1/14:1)cis showing a slight inhibition of cell proliferation at
1mM PC (Fig. 1B). Interestingly, all trans PCs displayed greater interfer-
ence with proliferation than their respective cis conﬁgured counter-
parts, with toxicity increasing with shorter chain length. This effect
was more pronounced with MAT-B-III cells than with CHO cells
(Table 1). Interestingly, PC(14:1/14:1)trans showed elevated toxicities
at higher concentrations in all the cell lines we investigated (IC50 rang-
ing from 130–550 μM).
In contrast to monounsaturated PCs, all diacyl-PCs containing fatty
acids with two or more double bonds in sn-1 and sn-2 positions
displayed signiﬁcant cell-proliferation inhibition (Fig. 1C). The long
chain ω-3 PC(22:6/22:6) was the most toxic PC investigated, with IC50
valueswell below100 μM.Again,we cannot claim that there is a general
tendency toward increasing toxicity in conjunction with increasing
chain length or the number of double bonds. Interestingly, the ω-3
PCs PC(18:3/18:3) and PC(22:6/22:6) revealed greater toxicity than
the respective ω-6 PC(20:4/20:4).
Except for PC(16:0/16:0) and PC(18:1/18:1), diacyl-PCs with similar
FAs are not common inmammalian cells [3]. To revealwhether the fatty
acid position plays a key role in the toxicities observed, we investigated
differentmixed chain PCs also (Fig. 1D). In these experiments, themax-
imum concentration was 2 mM liposomal PC in order to have the sameamount of a potentially toxic FA as with 1 mM diacyl-PC. These as well
as further investigations were done on CHO cells only, since we had ob-
served no general differences between the investigated cell lines as stat-
ed above. As expected, PCs with PUFAs in the sn-2 position showed a
certain degree of toxicity, but the IC50 values were all N1 mM. Most
strikingly, interference of PC(16:0/22:6) and PC(16:0/20:4) was not
seen at concentrations b1 mM, while the respective diacyl-PCs showed
much lower IC50 values (~80 μM for PC(22:6/22:6) and ~280 μM for
PC(20:4/20:4)). Thus non-natural diacyl-PCs containing PUFAs in the
(common) sn-2 position and in the sn-1 position show signiﬁcantly
higher toxicity than their naturalmixed-chain counterparts that is unre-
lated to the total amount of PUFAs delivered to the cell. Within natural
mixed-chain PCs, the unsaturated PC is usually found in the sn-2 posi-
tion, but the non-natural additional PUFAs in the sn-1 position seemed
to add signiﬁcantly to the toxicities we observed.
Absolute IC50 values depend on cell type andmany boundary condi-
tions such as the media being used, cultivation period, cell density, etc.
The estimated values are very useful to compare the effects of different
PCs within the described set of conditions, but should be considered
cautiously when applied to other conditions like in vivo situations. Al-
though absolute IC50 values vary, the overall trend is robust and repro-
ducible for all the cell lines we have investigated so far.
3.2. Proliferation time course
Several diacyl-PCs displayed signiﬁcant cell-proliferation inhibition
compared with untreated controls. A more detailed analysis of the
time course of cell proliferation was done for PC(12:0/12:0), PC(14:1/
14:1)trans and PC(18:3/18:3) with different concentrations (Fig. 2).
For these experiments, we regarded the vitality of cells present at t =
0 as being 100% vital. The untreated control showed normal growth be-
havior; the cells grew 2–2.5 folds within the ﬁrst 24–48 h with growth
slowing down afterwards. As expected, all PCs in low concentrations
(0.05 mM) demonstrated no or minimal effect on cell proliferation.
PCs present at 0.25 mM inhibited cell proliferation signiﬁcantly, de-
pending on the IC50 of the given lipid. When PCs were present in con-
centrations above their respective IC50 (1 mM), all three lipids showed
a decline in initial cell vitality, indicating the ability of these PCs to kill
a certain amount of cells in the initial population. PC(18:3/18:3) killed
the entire cell population within 24 h when present at 1 mM.
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proliferation wasmeasured via MTT-assay. The MTT signal of untreated cells at the begin-
ning of the experiment (t = 0) was deﬁned as 100% and proliferation/cell vitality is given
as respective percent. Untreated cells are shown in black (control). PC(12:0/12:0) is
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Fig. 3.Uptake of liposomal lipid. CHO-K1 cells were grown in the presence of radioactively
labeled liposomes (70 mol% PC/30 mol% cholesterol). A) Liposomes were marked with
[1,2-3H]cholesterylhexadecylether and speciﬁc radioactivities of liposomal suspensions
(counts/μmol PC) were determined. Cell associated liposomal lipid was calculated based
on the amount of radioactivity associated with the cells (mean and exemplary s.d. of
n = 3). B) Liposomes were marked with I-α-dipalmitoyl-1-14C-phosphatidylcholine
PC(16:0⁎/16:0⁎) as a marker that can be hydrolyzed and taken up as FFA and lyso-PC as
well as [1,2-3H]cholesterylhexadecylether as an uncleavable liposome marker. Uptake of
both marker lipids is given as percentage of respective total radioactivity present in the
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cell vitality drops within the ﬁrst 10 h after adding PC(14:1/14:1)trans
liposomes, remaining constant thereafter. Whether the constant cell vi-
abilitywe observed is a result of growth arrest or a steady state between
growing and dying cells cannot be determined by the methods used.
3.3. Uptake
To rule out that the impact of certain PCs on cell proliferationwe ob-
served is related to various amounts of liposomal PCs reaching the cells,
liposomes were labeled by [3H]cholesterylhexadecylether as a non-
exchangeable membrane marker. The amount of cellular liposomal
lipid was estimated for PC(12:0/12:0), PC(14:1/14:1)trans and
PC(18:3/18:3) as lipids showing elevated toxicity, and PC(14:1/14:1)
cis and PC(16:0/16:0) as lipids revealing no or minimal interference
with cell proliferation (Fig. 3). To compare lipids in a relevant concen-
tration range, uptake was measured at a concentration of 0.5 mM over
a 12 h period. While 0.5 mM is well beyond the IC50 of respective
toxic lipids in long-term experiments, we observed cell killing only
within the ﬁrst hours at higher concentrations (see Fig. 2). As the signif-
icant toxicity of the lipids we investigated appeared within the ﬁrst
hours (see Fig. 2), experiments were not continued for longer than 12 h.
Cellular uptake followed a typical endocytosis pattern revealing lin-
ear initial uptake and saturation over time. As Fig. 4 illustrates, we ob-
served no general differences in cellular uptake between these PCs.
Uptake of the more toxic PCs PC(12:0/12:0) and PC(18:3/18:3) oc-
curred slightly more slowly than uptake of the less toxic PCs. The vary-
ing toxicities we observed are thus not a result of the toxic liposomes'
higher rates of uptake.
Brügger et al. reported a total amount of ~21 pmol PC per 1000 CHO
cells. In our hands 1000 CHO cells had a protein content of ~0.37 μg.
Thus, a total uptake of about 10 pmol PC/μg cellular protein after 24 h
(see Fig. 3) converts to 3.7 pmol PC/1000 cells. According to this, the li-
posomal PC taken up by the cells corresponds to about 18% of the total
cellular PC, as a rough estimate.
3.4. Contribution of lysolipids
Degradation of PCs yields lyso-PC and FFA. Both arewell known to be
toxic to cells. The elevated toxicities of certain PCs might be related tolysolipid toxicity, while the PCs themselves exhibit no elevated interfer-
ence with cell proliferation. To rule out this hypothesis, we subjected
cell culture supernatant to TLC (Fig. 4A). No lysolipid was seen for
PC(18:3/18:3), PC(14:1/14:1)trans and PC(16:0/16:0) after up to 36 h
of observation. To detect trace amounts of lysolipid, we added di-[14C]
palmitoyl-phosphatidylcholine to some liposomes. Again, no lysolipid
was detected in the supernatant (Fig. 5B). Thus there is no
accumulation of lysolipid (and FFA) in the cell culture supernatant,
leading to interference with cell proliferation. Lysolipids and FFAs
are readily taken up by cells [9]. Lysolipid products might not accu-
mulate in cell culture supernatant, but they may be taken up by the
cells in signiﬁcant amounts to reveal toxicity. To rule out this mech-
anism, liposomes carrying di-[14C]palmitoyl-phosphatidylcholine
and [3H]cholesterylhexadecylether were added to cells and the
amounts of cell-associated radioactivity measured (Fig. 3B). In case of
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cells' uptake of these degradation products, the amount of radioactivity
related to the –[14C]acyl chains should bemuch higher than that of cell-
associated radioactivity related to the liposome membrane marker
[3H]cholesterylhexadecylether. As shown in Fig. 3B, we observed
no signiﬁcant differences in markers associated with the cells, indicat-
ing no signiﬁcant uptake of PC-degradation products. Thus, the differ-
ences observed in cell proliferation and toxicity are not mediated by
the degradation of respective PCs into lysolipids and FFA.
4. Discussion
PCs are a group of substances chemically characterized by their cho-
lineheadgroup linked via a phosphodiester to glycerol. Two varying acyl
chains are esteriﬁed in sn-1- and 2-positions of the glycerolmoiety, cre-
ating many different species. PCs were initially characterized from nat-
ural extracts like egg or soy PC. Not surprisingly, these PC mixtures
proved to be non-toxic in vitro [5] and in vivo [28,7]. Over the years,
more and more synthetic PCs became available. Interestingly, PCs still
are generally regarded as non-toxic even though these synthetic com-
ponents have never undergone systematic assessment.We used neutral
liposomes with a ﬁxed content of cholesterol and a single PC species.
These liposomes were taken up by the cells in nearly equal amounts, ir-
respective of the differences in FA acyl-chain composition (Fig. 3). Incontrast to FFAs revealing varying bioavailability due to different bind-
ing and uptake characteristics, the liposomal approach enabled us to di-
rectly compare the effects of PCs with different FAs on cell proliferation.
Except for the (non-toxic) PC(16:0/16:0), PC(16:1/16:1) and PC(18:1/
18:1), diacyl-PCs are not common in nature, neither in yeast [2] nor
mammalian cells [3]. Natural extracts like soy or egg PC are already
known to be non-toxic, and the mixed-chain PCs investigated in this
project showed no signiﬁcant inhibition of cell proliferation as well,
thereby supporting the notion that PCs from natural extracts are non-
toxic in general. These efforts thus focused on synthetic diacyl-PCs to
elucidate the effects of a single species of FA component and possibly
identify a certain subset of toxic PCs to possibly create a toxic carrier
for toxic drugs.
A small set of diacyl-PCs displayed signiﬁcant toxicity to different
cell lines, while most other PCs did not interfere with cell proliferation
at concentrations up to 2 mM. This work investigated interference
with cell proliferation with different mammalian and human cell lines.
All the PCs revealing proliferation-inhibiting potential displayed the
same overall effect on all the cell lines we investigated, with slight var-
iations in IC50 values (Table 1). Interestingly, we observed few general
rules concerning structure–toxicity relationships. For saturated PCs,
short chain diacyl-PCs PC(12:0/12:0) and PC(10:0/10:0) interfered sig-
niﬁcantly with cell proliferation, while PC(14:0/14:0) had no effect. In-
terestingly, the natural PC(16:0/16:0) always demonstrated slight cell-
proliferation inhibition at concentrations ≥0.5 mM, and we estimated
an IC50 of ~0.9 mM for HL-60 cells. Probably, natural PC(16:0/16:0) is
readily incorporated into cellularmembranes, thereby decreasing ﬂuid-
ity, while larger saturated PCs tend to be metabolized. Fatty acids func-
tion as a natural defense against bacteria in several species including
humans [12], and among saturated FAs, FA(12:0) showed remarkably
high antibacterial activity [29]. Membrane leakage, disrupted protein–
membrane interaction and disrupted oxidative phosphorylation are
currently being considered as antibacterial mechanisms [12].
Monounsaturated FAs in PCs from natural sources are usually cis-
conﬁgured. During our experiments, only PC(14:1/14:1)cis displayed a
slight inhibition of proliferation at higher concentrations. Not surpris-
ingly, the natural cellular diacyl-PCs PC(16:1/16:1)cis and PC(18:1/
18:1)cis revealed no toxicity. In contrast, monounsaturated diacyl-PCs
in trans-conﬁguration were all signiﬁcantly more toxic than their re-
spective cis-diastereomers. Again, there is a tendency to higher toxicity
in conjunction with shorter chain length. Trans-FAs have been char-
acterized as a nutritional health hazard for years [20], but unfortu-
nately there have been no systematic investigations on the cellular
level. Zapolska-Dovnar et al. demonstrated apoptosis induced by
FA(18:1)trans and FA(18:2)trans, but the percentage of cells in apopto-
sis was low even when 5 mMwere used [30]. Trans-FAs possess mem-
brane properties that are more similar to their unsaturated parent than
to their cis-conﬁgured sister [31]. Since PC(14:0) revealed no interfer-
ence with cell proliferation, perturbations in membrane properties by
PC(14:1/14:1)trans are unlikely to explain the toxicity we observed.
N-myristoyltransferase (NMT) is an essential enzyme for cellular prolif-
eration, and NMT inhibition has been discussed as an anticancer-
therapy option [32]. FA(14:1)trans showed similar KM and Vmax as
FA(14:0) itself, while FA(14:1)cis had higher KM and signiﬁcantly
lower Vmax than PC(14:1/14:1)trans. Calculating relative speciﬁcity
constants KSrel (=Vmax/KM) from this data, KSrel for FA(14:1)trans is
about 72% of KSrel for FA(14:0), while KSrel for FA(14:1)cis is only ~9%
of KSrel of FA(14:0). The resulting peptides of the monounsaturated
FAs were less hydrophobic than the peptides properly coupled to
FA(14:0) [33]. A disturbance of myristylation patterns and thereby pro-
tein sorting and function may underlie the PC interferences we ob-
served for PC(14:1/14:1). Interestingly, FA(12:0) and FA(10:0) are
also potential substrates of NMT, with FA(12:0) showing a KSrel of
120%, even higher than the “proper” substrate FA(14:0) [33]. Interfer-
ence with NMT may also contribute to the PC(12:0/12:0) toxicities we
noted. High concentrations of trans-FA-PCs reduce proliferation
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diacyl-PCs investigated in this project. Whether the same holds true
for trans-FFAs or trans-FAs in nutritional triglycerides cannot be con-
cluded by our ﬁndings, since metabolism and uptake are different.
All the polyunsaturated diacyl-PCswe investigated showed elevated
interference with cell proliferation, and polyunsaturated diacyl-PCs
were themost toxic PCs observed. Interestingly, PC(18:2)cis already re-
vealed markedly increased toxicity, while PC(18:1/18:1)cis demon-
strated no interference at all. However, FFA(18:2)trans displayed only
moderate toxicity on HUVEC cells [30], probably because the trans
isomer leads to similar membrane structures as in FA(18:0), while the
divenyl-methane structures of FA(18:2)cis led to the membrane
perturbations common for PUFAs. Despite PC(22:6/22:6) being the
most toxic PC we investigated, we detected no general rule concerning
chain length or number of double bonds. As ω-3 FAs show anti-
inﬂammatory effects, they are often considered beneﬁcial [34], while
pro-inﬂammatory ω-6 FAs are often regarded as unhealthy, although
debate continues [19]. On the cellular level regarding PCs, we observed
no differences between the toxicities ofω-6 andω-3 conﬁgured diacyl-
PCs. More likely, any observed differences between these species arise
on a systemic level, where ω-6 and ω-3 FAs oppose each other's pro-
and anti-inﬂammatory effects.
PUFAs have been investigated as anticancer agents, and IC50 values
between 1 and 10 μM have been observed on Mia-Pa-Ca-2 cells and
HL-60 cells [13], with a slight increase in toxicity with increasing num-
bers of double bonds. OnMCF-7 cells, 50% inhibition of cell growth was
not attained at 30 μM for all the PUFAs we investigated except for
FA(22:6). FA(18:2) demonstrated no inhibition whatsoever. During
these experiments, media were supplemented with fetal bovine
serum, albumin and FA(18:1), thereby possibly counteracting certain
toxicities [14]. In this investigation, PC-liposomes were used as well,
and the PCs showed effects similar to those of the corresponding FFAs.
On Jurkat cells, 50% growth inhibition by PUFAs was observed around
approx. 50 μM or less while FA(18:1) showed no inhibition [15].
Taken together, PUFAs and their respective non-physiological diacyl-
PCs reveal similar toxic potential, although they may differ in uptake
routes and the mechanisms leading to cell death.
PUFAs are much more susceptible to oxidation than other FAs, and
oxidized FAs are closely associated with oxidative stress [35]. PUFAs
have been reported to cause apoptotic cell death presumably via oxida-
tive stress [13], and enhanced oxidative stress may likely contribute to
the toxicities of respective PCswe observed.Mixed chain PCs containing
PUFAs showed no or minimal interference with cell proliferation
(Fig. 1D), even when the same amounts of FAs were present. Natural
mixtures usually contain mixed-chain PCs for the most part, and these
ﬁndings are in line with an earlier examination [5] in which these mix-
tures' compatibility with cell proliferation was already proven. Since
these mixed-chain PCs are much less toxic than their synthetic diacyl-
PC counterparts even when the same amounts of PUFAs are delivered
to the cells, oxidative stress caused by delivered PUFAs cannot be the
sole cause of the toxicities we observed. Natural mixed-chain PCs con-
tain only a single polyunsaturated FA usually in sn-2 positionwith a sat-
urated FA in sn-1 position [36], and PUFAs in non-natural sn-1-position
seem to be a source of elevated toxicity. Possibly, natural mechanisms
(such as defense mechanisms against PUFAs' oxidative modiﬁcation)
are less well-equipped to deal with oxidized PUFAs in the sn-1 position.
Substantial differences in biophysical membrane properties were re-
corded between ω-6 PC(16:0/20:4) and ω-3 PC(16:0/22:6) [37], but
the similar toxicities we observed cannot be attributed to these differ-
ences. In this study, a model was proposed displaying the tip of the
bulky PUFA in sn-2 position extending into the intermembrane space
beyond the end of the FA(16:0) in sn1-position, thereby containing a
PC's overall cylindrical shape. With regard to a second PUFA in sn-1 po-
sition, such a conﬁguration is no longer possible, probably leading to a
more conical shape for the diacyl-PC's and thereby to alterations in
membrane integrity.PCs might be cloven into FFAs and lysolipid, and both components
are known to be toxic. Within our study's time span, we detected no
cleavage of liposomal PCs outside the cells. Thus the effects on prolifer-
ation we observed are mediated by the uptake of given liposomal PCs,
but once within the cells, the PCs might be cloven into respective FFAs
and lysolipids. There is evidence that LPC(18:0) inhibits growth on dif-
ferent cell lines with IC50-values between 120 and 180 μM [38]. Report-
ed LPC(18:0) toxicity contrasts with that of long-chain saturated PCs,
which did not display elevated growth inhibition in our experimental
setting. Furthermore, LPC(17:0) is known to be effective against metas-
tasis by altering the surface structure of cancer cells in vivo [9]. No tox-
icity was reported in vitro for LPC(17:0) and LPC(16:0) on cancer cells
even though these LPC were administered repeatedly over several
days at a concentration up to 450 μM. As with FFA, experimental condi-
tions such as albumin concentration may affect observed toxicities.
Liposomes are readily taken up by cells primarily via endocytosis,
while the cellular uptake of phospholipids is more likely obtained via
speciﬁc lipid transfer under physiological conditions [18]. Since endocy-
tosis does not seem to distinguish between different liposomal PCs, this
entry route probably circumvents cellular regulation of PC uptake. As a
rough estimate, about 18% of our cellular PC was taken up by the cells
within 24 h. With regard to just one non-natural diacyl-PC species,
this is a fairly high amount. Interestingly, a similar amount of incorpo-
rated FFA into MCF-7 cells has been measured for FFA [14]. Unspeciﬁed
endocytosis of liposomal PC may be a sort of “back-door” entry for PC
that may lead to lipid overload which can be managed with natural
mixed-chain PCs and most diacyl-PCs, but certain non-physiological
diacyl-PCs pose a toxic threat to the cells.
Once taken up, PCs are used either as membrane building blocks
without modiﬁcation or they are metabolized. Headgroup exchange is
a common route of metabolizing PCs, generating phosphatidylserine
(PS) and phosphatidylethanolamine (PE). Both components play a cru-
cial role in membrane asymmetry [39]. A disturbance of these com-
pounds' function may contribute to the observed effects as well.
Interestingly, remarkable differences between PC, PS and PE occur re-
garding FA acyl chain composition, leading to the assumption that dif-
ferent routes of lipid homeostasis must exist for PC, PS and PE [36].
With a fairly high amount of a single PC species entering the cells, PS
and PE homeostasis might be disturbed as well.
Since there is no obvious rule concerning toxicity, different mecha-
nisms might be behind the interferences with cell proliferation that
we observed in conjunction with some PCs. So far, these underlying
mechanisms are a matter of speculation, and more detailed investiga-
tion will be the focus of further work.
The hypothesis of using FAs against cancer was developed decades
ago [40], and several studies showed PUFAs' beneﬁcial effects against
cancer [13,14]. The use of hybrid liposomes consisting of essential
non-toxic PC(14:0) and PUFAs is ameans of combining liposomal deliv-
ery technique with FAs' antitumor efﬁciency [16]. Another way to com-
bine these techniques is to employ certain toxic diacyl-PCs as suggested
by the data presented in this work. Essential non-toxic PCs like HSPC
have been used in liposomal anticancer drug delivery for years. The
toxic diacyl-PCs we have identiﬁed could perhaps be used to construct
a toxic shell, enhancing the impact of a transported cytostatic drug.
Targeted drug delivery and anticancer properties would thereby be
combined within a single vehicle by choosing the appropriate PC.
Chemotherapeutic agents show IC50 concentrations in the μM range,
e.g. doxorubicin has an IC50 value around 1 μM, vincristine around
4.6 μM [41]. IC50 values for the most “toxic” diacyl-PCs PC(22:6/22:6),
PC(20:4/20:4) and PC(18:3/18:3) were well below 100 μM, revealing
some toxic potential. On the other hand, the same toxicity pattern has
been observed on all cell lines investigated so far, and generally high
toxicitymay create a narrow therapeuticwindow for a given “toxic” car-
rier. A moderately-toxic lipid like PC(12:0/12:0) or PC(14:1/14:1)
would probably be more appropriate for constructing a toxic shell for
chemotherapeutic agents. In terms of pegylated liposomal doxorubicin,
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(for a rough estimation, see supplement), and adding a second con-
straint on cell proliferation via toxic PCsmight present a realistic option.
Several other aspects of drug delivery beyond synergistic toxicities, such
as systemic toxicity, drug entrapment, shelf life, etc. must be taken into
account to enable successful in vivo drug delivery. We maintain that it
might proveworthwhile to assess someof the PCs that potentially inter-
fere with cell proliferation for improved drug delivery.
5. Conclusion
Most of the diacyl PCswe investigated revealed no elevated interfer-
encewith cell proliferation at concentrations up to 1mM. The samewas
true regarding all the mixed-chain PCs we investigated. Our data thus
support the notion that most PCs are safe excipients. Certain non-
natural diacyl-PCs, however, do display marked interference with cell
proliferation, namely all non-physiological diacyl-PCs containing
PUFAs and short-chain saturated PCs, aswell as trans-conﬁguredmono-
unsaturated PCs. Since there are no evident comprehensive rules
concerning FA structure, these PCs might perform via different mecha-
nisms. These “black sheep” deserve further investigation to explore
the potential of constructing a “toxic carrier for toxic drugs”.
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